NextPoint Therapeutics, Inc. Alternatives & Competitors
12 companies similar to NextPoint Therapeutics, Inc. — Launching a new world of precision therapeutics through its leading scientific...
Immatics
The Global Leader in Precision Targeting of PRAME
Germany
Radionetics Oncology
Discovering and developing novel radiotherapeutics for the treatment of cancer.
San Diego, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
PhotonPharma
An immuno-oncology company unleashing the body to fight cancer
Fort Collins, United Stat...
Track all NextPoint Therapeutics, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
TFC Therapeutics
We are a biotechnology company focused on developing novel biologics to target and elimina...
New York, United States
Affini-T Therapeutics
Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...
Watertown, United States
Brenus Pharma
Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Lyon, France
Flare Therapeutics
Trailblazing the path to drugging transcription factors to discover precision medicines fo...
Cambridge, United States
Incyclix Bio
Regaining Cell Cycle Control
Durham, United States
AffyImmune Therapeutics
Biotechnology startup developing Tune & Track platform to expand utility & improve safety...
Natick, United States
BlossomHill Therapeutics, Inc.
Addressing urgent unmet medical needs through deeper science, true originality, and rich e...
San Diego, United States
T-Therapeutics Ltd
Making T-Cell Receptor Biologics a Reality
Cambridge, United Kingdom
About NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on the novel B7-H7 axis
Drug Development, Precision Medicine, Clinical Trials, Biomarker Identification
Cancer Patients, Oncologists, Healthcare Providers, Biopharmaceutical Researchers
Precision Therapeutics, Cancer Immunotherapy, B7-H7/HHLA2 Axis, Antibody-Drug Conjugate, Proprietary Linker Technology, T-cell Engager, Checkpoint Inhibitor, Clinical Biomarker, PD-1/L1 Alternative, Adaptive Immune System, Innate Immune System, Tumor-Targeting Modalities, Therapeutic Window, Cancer Biomarker Modulation, Clinical-stage Biotechnology
B2B, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches NextPoint Therapeutics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at NextPoint Therapeutics, Inc. on 28 Jan 2026. The 12 companies listed here were last checked between 17 Sep 2025 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.